Dr. David Klug

Biography

David Klug is a Professor of Chemical Biophysics at Imperial College London, specializing in multidisciplinary research and novel ways of working. He joined the Department of Chemistry in October 1998, and previously held joint positions in the Departments of Biochemistry and Chemistry. His academic career began as a Royal Society University Research Fellow from October 1990 to September 1995, focusing on Biochemistry and Chemistry. David graduated with a degree in Physics from University College London in 1984 and obtained his Ph.D. from the Royal Institution in 1987. He is a co-founder of the Institute of Chemical Biology, where he coordinates teaching and research activities. David has chaired the Single Cell Proteomics Project, a £5 million multidisciplinary collaboration involving eight research teams to develop and apply novel platform technologies for high-throughput single cell analysis. His current research interests include platform technologies for drug-target binding analysis and single-molecule-sensitive affinity assays for rare human primary cells. Additionally, he serves as the Associate Dean for Enterprise at Imperial College, working with start-ups and strategic partners to bring inventions to the greater socio-economic benefit. He is also the Chief Scientific Officer at Panacea Diagnostics, focused on the development of a universal platform for health monitoring and early disease detection.

Research Interests